GNFT
Genfit SA Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website genfit.com
- Employees(FY) 154
- ISIN US3722791098
Performance
+2.57%
1W
+1.75%
1M
+0.84%
3M
+8.46%
6M
-6.75%
YTD
-15.97%
1Y
Profile
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
Technical Analysis of GNFT 2024-05-03
Overview:
In analyzing the technical indicators for GNFT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-04-25 04:10
- 2024-04-15 04:10
- 2024-04-05 02:00
- 2024-04-04 04:10
- 2024-02-29 03:10
- 2024-01-15 03:10
GENFIT Announces 2024 Financial Calendar(Yahoo Finance)
- 2024-01-11 03:10
- 2023-12-07 12:55
- 2023-12-06 16:15
- 2023-12-05 22:30
- 2023-11-16 03:10
- 2023-11-13 03:30
- 2023-11-09 03:10
GENFIT Reports Third Quarter 2023 Financial Information(Yahoo Finance)
- 2023-11-02 05:10
- 2023-09-26 04:10
- 2023-09-20 04:10
- 2023-09-05 04:10
GENFIT to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2023-08-10 04:10
- 2023-07-12 04:10
- 2023-06-29 13:00
- 2023-06-07 04:10
- 2023-05-31 04:44
- 2023-05-31 04:10
- 2023-05-24 01:00
GENFIT: May 24, 2023 Combined Shareholders Meeting results(Yahoo Finance)
- 2023-05-23 04:10
- 2023-05-11 04:10
GENFIT Reports First Quarter 2023 Financial Information(Yahoo Finance)
- 2023-05-09 04:10
- 2023-04-27 04:10
- 2023-04-19 04:10
- 2023-04-18 04:10
Page 1 of 4
previousnext